Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 7/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19061994 | 0.99 | PDE10A (0.34) | KDM4EATML3MBTL1PDE10APDK2 | |
| SCHEMBL19061448 | 0.99 | KDM4E (0.33) | KDM4EATML3MBTL1PDE10APDK2 | |
| SCHEMBL19061276 | 0.99 | PDE10A (0.34) | KDM4EATML3MBTL1PDE10APDK2 | |
| SCHEMBL17714885 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1PDE10APDK2 | |
| SCHEMBL19061500 | 0.98 | PDE10A (0.33) | KDM4EATML3MBTL1PDE10APDK2 | |
| SCHEMBL18385199 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL19061538 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL18385527 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL18385546 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1PDE10AALDH1A1 | |
| SCHEMBL18565857 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1PDE10APDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690287-B2 | Organic light-emitting device and display apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11690287-B2 | Organic light-emitting device and display apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20210257559-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
| US-20200203621-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| US-20170186975-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| US-20170186975-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690287-B2 | Organic light-emitting device and display apparatus including the same | OR10J3, ALDH1A2, OCIAD1 | KDM4E 3054/4885ATM 4140/4885L3MBTL1 1229/4885 |
| US-20200203621-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS INCLUDING THE SAME | OR10J3, ALDH1A2, OCIAD1 | KDM4E 3054/4885ATM 4140/4885L3MBTL1 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.